Development of a Fully Automated FASTlab 2 Process for [ 18 F]AlF Radiolabelling of NOTA Peptide Conjugates
Journal of Labelled Compounds and Radiopharmaceuticals · 2026-04 · 69 (4-6)
DOI: 10.1002/jlcr.70030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 09.04.2026. Verfasst von Imtiaz Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: GE HealthCare, Pharmaceutical Diagnostics, Pollards Wood, Nightingales Lane, Bucks, UK. Hauptthemen laut MEDLINE: Fluorine Radioisotopes, Isotope Labeling, Fluorides, Aluminum Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Aluminium[ 18 F]fluoride ([ 18 F]AlF) radiochemistry offers an attractive alternative to conventional radiometals for peptide and protein labelling and has been applied in several clinical radiopharmaceuticals. The method combines the broad availability of [ 18 F]fluoride with rapid aqueous‐phase labelling under mild conditions, making it well suited to biomolecules sensitive to organic solvents or elevated temperatures. To enable routine clinical translation, we developed a fully automated [ 18 F]AlF radiolabelling process on the GE HealthCare FASTlab 2 synthesis platform using NOTA‐AMBA as a model compound. Formulated [ 18 F]AlF‐NOTA‐AMBA was produced with a non–decay‐corrected radiochemical yield of 63.3% ± 5.0% ( n = 3) in a total synthesis time of 20 min. The radioactive concentration at end of synthesis was 831 ± 115 MBq/mL, with a radiochemical purity of 94.1% ± 0.5%. The molar activity was 183.3 ± 20.7 GBq/μmol. No dissociation of [ 18 F]AlF from the NOTA chelator was observed over 4 h at room temperature, confirming excellent stability. A simple, rapid and fully automated [ 18 F]AlF labelling method has been established on FASTlab 2. High yields were achieved using low precursor amounts (95 μg, 67.5 nmol) without HPLC purification. The method is readily adaptable to GMP‐compliant production of [ 18 F]AlF‐labelled biomolecules for clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GE HealthCare, Pharmaceutical Diagnostics, Pollards Wood, Nightingales Lane, Bucks, UK.
- Perceptive Discovery, London, UK.
ORCID-Profile: Imtiaz Khan
Zitieren
APA
Khan, I., Shales, J., McCluskey, S., McRobbie, G., & Grigg, J. (2026). Development of a Fully Automated FASTlab 2 Process for [ 18 F]AlF Radiolabelling of NOTA Peptide Conjugates. Journal of Labelled Compounds and Radiopharmaceuticals, 69(4-6). https://doi.org/10.1002/jlcr.70030
Vancouver
Khan I, Shales J, McCluskey S, McRobbie G, Grigg J. Development of a Fully Automated FASTlab 2 Process for [ 18 F]AlF Radiolabelling of NOTA Peptide Conjugates. Journal of Labelled Compounds and Radiopharmaceuticals. 2026;69(4-6). doi:10.1002/jlcr.70030
BibTeX
@article{Khan2026,
author = {Khan, Imtiaz and Shales, Jon and McCluskey, Stuart and McRobbie, Graeme and Grigg, Julian},
title = {Development of a Fully Automated FASTlab 2 Process for [ 18 F]AlF Radiolabelling of NOTA Peptide Conjugates},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2026},
volume = {69},
number = {4-6},
doi = {10.1002/jlcr.70030}
}
EUVIMED